Chemcrux Enterprises Ltd Multibagger Analysis 2021
In this article, we are able to explore the chance of Chemcrux Enterprises Ltd as a Multibagger 2021 Stock supported worth investment principles. Intermediates and artificial compounds area unit utilised within the production of mass medications (API), electro-plating, drugs, colors, and shades.
Website | http://www.chemcrux.com/ |
CMP | 276 INR |
About Chemcrux Enterprises Ltd Multibagger
Chemcrux Enterprises is occupied with the Business of producing or process Bulk Drug intermediates like para, epidemic cholera carboxylic acid, and lacosamide, and then on To arise because the main maker in native and worldwide business sectors, for Intermediates and artificial compounds utilised within the collection of mass medications (API), electro-plating, drugs, colors, and shades. We, at Chemcrux, place stock in being ethical and doing the proper things systematically.
Chemcrux Enterprises Ltd. engages in the manufacture of intermediates for bulk drugs, dyes, electro-plating, pharmaceuticals, and pigments. It specializes in oxidation, nitration, acetylation, and chlorosulfonation chemistry. The firm’s products include ortho chloro benzoic acid, meta chloro benzoic acid, para chloro benzoic acid, para nitro benzoic acid, dichlorobenzene carboxylic acid, dichloro benzoic acid, dichloro sulfamoyl benzoic acid, acetyl glycine, dichlorobenzene carboxylic acid, and chloro sulfamoyl benzoic acid. The company was founded by Girish Champaklal Shah and Sanjaybhai Yashwantrao Marathe in 1983 and is headquartered in Vadodara, India.
Chemcrux applies our huge level of expertise and experience to supply our colleagues with the ideal top-quality items, with administrations they can truly rely upon and, at whatever point important, with complete answers for broad issues.
Chemcrux Enterprises Ltd. engages within the manufacture of intermediates for bulk medicine, dyes, electro-plating, prescribed drugs, and pigments. It focuses on oxidization, nitration, acylation chemistry. The firm’s merchandise embrace ortho carboxylic acid, carboxylic acid, para nitro carboxylic acid, dichlorobenzene acid, dichloro carboxylic acid, dichloro sulfamoyl carboxylic acid, acetyl group glycine, dichlorobenzene acid, and sulfamoyl carboxylic acid. the corporate was based by Girish Champaklal sovereign and Sanjaybhai Yashwantrao Marathe in 1983 and is headquartered in Vadodara, India.
Chemcrux applies our large level of experience and skill to produce our colleagues with the best top-grade things, with administrations they’ll actually depend upon and, at no matter purpose necessary, with complete answers for broad problems.
CHEMCRUX dominates in air mass oxidization, Nitration, acylation, and Chlorosulfonation Chemistry – manufacturing intermediates for mass Drugs(API), Dyes and shade enterprises. an oversized range of them area unit import substitutes created while not precedent for the Asian nation.
The regarded consumer base in an Asian nation, incorporate various multinationals and reported drug association, as – well – as traditional fares to various nations – The consequence of consumer care with the responsibility that area unit dead at any expense and sent with safe bundling, taking care of and transport.
Capitalization | 136 Crore | ![]() |
Sales Increasing past 3 Years | Yes, 19.2 % | ![]() |
Profit Increasing past 3 Years | Yes, 56.0 % | ![]() |
Durable Competitive Advantage | Yes | ![]() |
Face Value | ₹ 10.0 | ![]() |
ROE | 27.5 % | ![]() |
Debt Equity Ratio | 0.06 | ![]() |
PE Ratio | 15.3 | ![]() |
PB Ratio | 5X | ![]() |
Intrinsic Value Discount | 93% | ![]() |
Promoter Holding & Increase | 50%, | ![]() |
Multibagger Returns | 300-500% 5 Year | ![]() |
Positives
- Above Average Sustainable RoE The organization produces a feasible profit from value more noteworthy than the normal expense of capital
- The business has an incredible money transformation proportion since it can change over a signifant bit of working income of 73.33% into working income.
- The company has almost nil to negligible debt to equity ratio of 0.06.
Negatives
- The organization works an amazingly repeating business with erratic profit and incomes
- The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.
- COVID affected business with De-growth in Revenue for FY20
Conclusion
CHEMCRUX dominates in High-Pressure Oxidation, Nitration, Acetylation, and Chlorosulfonation Chemistry – producing intermediates for mass Drugs(API), Dyes and color businesses. Large numbers of them are import substitutes produced without precedent for INDIA.
The regarded client base in India, incorporate numerous multinationals and rumored drug association, as – well – as ordinary fares to numerous nations – The consequence of client support with responsibility which is executed at any expense and conveyed with safe bundling, taking care of and transport.
Chemcrux, are resolved to be, Reliable Business accomplice to create, assembling, and supply intermediates for mass medications just as colors to meet client assumptions reliably.